This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carroll, R. E. Articles by Benya, R. V. Search for Related Content PubMed PubMed Citation Articles by Carroll, R. E. Articles by Benya, R. V.

Gastrin-releasing Peptide Is a Mitogen and a Morphogen in Murine Colon Cancer¹

Departments of Medicine [R. E. C., K. A. M., M. S. T., R. V. B.], Pathology [K. A. M.], and Pharmacology [R. V. B.] University of Illinois at Chicago, and Chicago Veterans Administration Medical Center (West Side Division) [R. E. C., K. A. M., M. S. T., R. V. B.], Chicago, Illinois 60612, and National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, Maryland 20892 [J. F. B.]

Abstract

Little is known about the factors involved in regulating the appearance, or differentiation, of solid tumors including those arising from the colon. We herein demonstrate that the mitogen gastrin-releasing peptide (GRP) is a morphogen, critically important in regulating the differentiation of murine colon cancer. Although epithelial cells lining the mouse colon do not normally express GRP and its receptor (GRP-R), both are aberrantly expressed by all better differentiated cancers in wild-type C57BL/6J mice treated with the carcinogen azoxymethane. Whereas small tumors in both wild-type and GRP-R-deficient (i.e., GRP-R^-/-) mice are histologically similar, larger tumors become better differentiated in the former but degenerate into more poorly differentiated mucinous adenocarcinomas in the latter. This alteration in phenotype is attributable to GRP increasing focal adhesion kinase expression in GRP-R-expressing tumors. Consistent with GRP acting as a mitogen, GRP/GRP-R coexpressing tumors in wild-type animals also contain more proliferating cells than those occurring in GRP-R^-/- mice. Yet tumors are similarly sized in animals of either genotype receiving azoxymethane for identical times, a finding attributable to the significantly higher number of apoptotic cells detected in GRP/GRP-R coexpressing cancers. Thus, these findings indicate that although GRP is a mitogen, aberrant expression does not result in increased tumor growth. Rather, the mitogenic properties of GRP are subordinate to it acting as a morphogen, where it and its receptor are critically involved in regulating colon cancer histological progression by promoting a well-differentiated phenotype.

This article has been cited by other articles:

				J. Qiao, J. Kang, T. A. Ishola, P. G. Rychahou, B. M. Evers, and D. H. Chung Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma PNAS, September 2, 2008; 105(35): 12891 - 12896. [Abstract] [Full Text] [PDF]

				R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42. [Abstract] [Full Text] [PDF]

				L. Taglia, D. Matusiak, K. A. Matkowskyj, and R. V. Benya Gastrin-releasing peptide mediates its morphogenic properties in human colon cancer by upregulating intracellular adhesion protein-1 (ICAM-1) via focal adhesion kinase Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G182 - G190. [Abstract] [Full Text] [PDF]

				S. Glover, R. Nathaniel, L. Shakir, C. Perrault, R. K. Anderson, R. Tran-Son-Tay, and R. V. Benya Transient upregulation of GRP and its receptor critically regulate colon cancer cell motility during remodeling Am J Physiol Gastrointest Liver Physiol, June 1, 2005; 288(6): G1274 - G1282. [Abstract] [Full Text] [PDF]

				D. Matusiak, S. Glover, R. Nathaniel, K. Matkowskyj, J. Yang, and R. V. Benya Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G718 - G728. [Abstract] [Full Text] [PDF]

				Genetically Modified Animals in Endocrinology Endocr. Rev., August 1, 2004; 25(4): 673 - 677. [Full Text] [PDF]

				K. A. Matkowskyj, K. Keller, S. Glover, L. Kornberg, R. Tran-Son-Tay, and R. V. Benya Expression of GRP and Its Receptor in Well-differentiated Colon Cancer Cells Correlates with the Presence of Focal Adhesion Kinase Phosphorylated at Tyrosines 397 and 407 J. Histochem. Cytochem., August 1, 2003; 51(8): 1041 - 1048. [Abstract] [Full Text] [PDF]

				K. A. Matkowskyj, R. Cox, R. T. Jensen, and R. V. Benya Quantitative Immunohistochemistry by Measuring Cumulative Signal Strength Accurately Measures Receptor Number J. Histochem. Cytochem., February 1, 2003; 51(2): 205 - 214. [Abstract] [Full Text] [PDF]

				P. Gelebart, T. Kovacs, J.-P. Brouland, R. van Gorp, J. Grossmann, N. Rivard, Y. Panis, V. Martin, R. Bredoux, J. Enouf, et al. Expression of Endomembrane Calcium Pumps in Colon and Gastric Cancer Cells. INDUCTION OF SERCA3 EXPRESSION DURING DIFFERENTIATION J. Biol. Chem., July 12, 2002; 277(29): 26310 - 26320. [Abstract] [Full Text] [PDF]

				R. E. Carroll, D. Ostrovskiy, S. Lee, A. Danilkovich, and R. V. Benya Characterization of Gastrin-Releasing Peptide and Its Receptor Aberrantly Expressed by Human Colon Cancer Cell Lines Mol. Pharmacol., September 1, 2000; 58(3): 601 - 607. [Abstract] [Full Text]